MarketsStocksNOVELIX
NO

Novelix Pharmaceuticals Ltd

NSE: NOVELIXBSE: 536565Healthcare
59.88
+10.15%
NSE · 15-min delayed
Mkt Cap
₹118 Cr
P / E
38.1
P / B
2.5
ROE
5.5%
52W High
₹70.16
52W Low
₹29.33
Key Metrics
Market Cap
₹118 Cr
P / E
38.1
P / B
2.5
ROCE
6.7%
ROE
5.5%
Div Yield
-
Revenue · ₹ Cr
31
FY18
10
FY19
10
FY20
9
FY21
1
FY23
31
FY25
132
FY26
Net Profit · ₹ Cr
2
FY18
0
FY19
0
FY20
-4
FY21
0
FY23
0
FY25
3
FY26
EPS · ₹ per share
₹0.1
FY16
₹-0.0
FY19
₹-0.3
FY20
₹-4.6
FY21
₹-0.1
FY23
₹0.1
FY25
₹1.2
FY26
Q3 2022 snapshot
Sales
₹1 Cr
Operating profit
₹-0 Cr
OPM
-14.1%
Net profit
₹-0 Cr
EPS
₹-0.19
Scorecard · 7 axes
Quality
Good
69/100
Valuation
Avg
38.1×
Growth
Strong
+58.3%
Profitability
Weak
6.1%
Performance
Strong
+113.9%
Entry Point
Avg
85%
Red Flags
Strong
0 flags
Shareholding Pattern
49.4%Promoter
Promoter49.4%
Public50.6%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue5.320.8622.3536.3948.425.19
Net Profit0.1480.1830.1070.5331.0040.912
NPM %2.8%0.9%0.5%1.5%2.1%3.6%
AlertPre-trade